Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| LaPlume Joseph W | EVP, Corp Strategy & Develop | Aug 08 '24 | Sale | 199.36 | 1,780 | 354,861 | 22,521 | Aug 12 04:13 PM | | Joseph LaPlume | Officer | Aug 08 '24 | Proposed Sale | 196.63 | 1,780 | 350,000 | | Aug 08 01:34 PM | | FOSTER JAMES C | Chairman, President and CEO | Aug 01 '24 | Sale | 250.00 | 25,000 | 6,250,000 | 188,251 | Aug 05 04:04 PM | | FOSTER JAMES C | Officer | Aug 01 '24 | Proposed Sale | 250.00 | 25,000 | 6,250,000 | | Aug 01 04:07 PM | | MASSARO GEORGE | Director | May 15 '24 | Sale | 235.62 | 332 | 78,225 | 5,855 | May 16 04:35 PM | | LaPlume Joseph W | EVP, Corp Strategy & Develop | May 10 '24 | Sale | 226.97 | 1,304 | 295,969 | 23,276 | May 14 04:49 PM | | Knell Michael Gunnar | CSVP&Chief Accounting Officer | Mar 08 '24 | Sale | 267.52 | 808 | 216,156 | 7,024 | Mar 11 04:42 PM | | Knell Michael Gunnar | CSVP&Chief Accounting Officer | Mar 04 '24 | Sale | 261.05 | 2,750 | 717,890 | 7,832 | Mar 05 04:54 PM | | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Feb 29 '24 | Sale | 253.45 | 3,786 | 959,545 | 4,792 | Mar 04 04:09 PM | | Creamer Victoria L | EVP & Chief People Officer | Feb 29 '24 | Sale | 253.70 | 5,000 | 1,268,500 | 13,550 | Mar 01 05:37 PM | | Barbo William D | Corporate Executive VP & CCO | Feb 22 '24 | Sale | 248.50 | 4,050 | 1,006,425 | 22,879 | Feb 23 04:57 PM | | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Feb 15 '24 | Option Exercise | 144.67 | 5,882 | 850,949 | 8,478 | Feb 20 05:32 PM | | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Feb 15 '24 | Sale | 241.20 | 5,882 | 1,418,767 | 2,596 | Feb 20 05:32 PM | | LaPlume Joseph W | EVP, Corp Strategy & Develop | Feb 15 '24 | Sale | 238.93 | 838 | 200,223 | 24,620 | Feb 20 05:20 PM | | FOSTER JAMES C | Chairman, President and CEO | Jan 29 '24 | Option Exercise | 144.67 | 17,436 | 2,522,466 | 227,827 | Jan 31 04:59 PM | | Girshick Birgit | Corporate Executive VP & COO | Jan 10 '24 | Option Exercise | 215.19 | 5,916 | 1,273,064 | 50,365 | Jan 11 04:09 PM | | Creamer Victoria L | EVP & Chief People Officer | Dec 14 '23 | Option Exercise | 136.70 | 5,526 | 755,388 | 22,032 | Dec 18 04:07 PM | | Creamer Victoria L | EVP & Chief People Officer | Dec 14 '23 | Sale | 225.00 | 5,526 | 1,243,350 | 16,506 | Dec 18 04:07 PM | | LaPlume Joseph W | EVP, Corp Strategy & Develop | Nov 30 '23 | Sale | 197.73 | 1,850 | 365,800 | 23,133 | Dec 01 04:10 PM | | Girshick Birgit | Corporate Executive VP & COO | Nov 20 '23 | Buy | 187.82 | 1,322 | 248,298 | 44,449 | Nov 21 05:07 PM | | FOSTER JAMES C | Chairman, President and CEO | Nov 14 '23 | Buy | 178.05 | 5,620 | 1,000,641 | 202,643 | Nov 15 09:23 AM | | LaPlume Joseph W | EVP, Corp Strategy & Develop | Nov 09 '23 | Option Exercise | 144.67 | 9,128 | 1,320,548 | 34,111 | Nov 13 04:12 PM | | LaPlume Joseph W | EVP, Corp Strategy & Develop | Nov 09 '23 | Sale | 173.48 | 9,128 | 1,583,522 | 24,983 | Nov 13 04:12 PM |
|
